|1.||Mumper, Russell J: 5 articles (06/2010 - 02/2005)|
|2.||Clements, P J: 5 articles (04/2004 - 11/2000)|
|3.||Gupte, Anshul: 4 articles (02/2009 - 02/2005)|
|4.||Brewer, George J: 4 articles (02/2006 - 03/2003)|
|5.||Medsger, T A: 4 articles (06/2001 - 11/2000)|
|6.||Furst, D E: 4 articles (06/2001 - 11/2000)|
|7.||Dzieżyc, Karolina: 3 articles (10/2015 - 02/2014)|
|8.||Litwin, Tomasz: 3 articles (10/2015 - 02/2014)|
|9.||Członkowska, Anna: 3 articles (10/2015 - 02/2014)|
|10.||van den Ingh, Ted S G A M: 3 articles (01/2015 - 06/2013)|
07/01/1985 - "In 52 patients with severe rheumatoid arthritis the therapeutic efficacy of 600 mg/die of D-penicillamine was evaluated for two years in a prospective trial. "
09/01/1994 - "Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis."
10/14/1988 - "D-penicillamine is also effective in controlling the signs and symptoms of rheumatoid arthritis, but serious toxicity may occur. "
01/01/1988 - "The mechanism by which D-Penicillamine is effective in the treatment of rheumatoid arthritis has been investigated. "
11/01/1986 - "In 34 patients with severe rheumatoid arthritis the therapeutic efficacy of 600 mg/die of D-penicillamine was evaluated for five years. "
|2.||Hepatolenticular Degeneration (Wilson's Disease)
05/01/2009 - "Nevertheless, according to currently available data, patients with hepatic presentation of Wilson disease are probably most effectively treated by D-penicillamine. "
12/01/1984 - "The best treatment for fulminant Wilson's disease is prevention by diagnosis in a pre-symptomatic stage and institution of carefully supervised life-long therapy with penicillamine."
04/12/1986 - "A patient who presented with severe hepatic Wilson's disease at age 14 responded well to treatment with penicillamine and remained in good health for a further 20 years, although she became somewhat careless about her medication towards the end of this period. "
06/28/1999 - "Treatment with penicillamine in Indian childhood disease, which probable has the same etiology, is effective when it is started early enough as well as in Wilson's disease. "
09/01/1993 - "D-penicillamine, an orally-administered chelating agent, is effective for Wilson's disease (WD). "
01/01/1993 - "Long-term D-penicillamine treatment can be used in patients with cystinuria and is both effective and safe. "
11/01/1981 - "We conclude that D-penicillamine is useful in the treatment of cystinuria. "
11/01/1981 - "A retrospective study was conducted to assess the efficacy of D-penicillamine in the management of cystinuria, as well as to define the frequency and nature of untoward reactions to this drug. "
12/01/2008 - "We reviewed the charts of all 11 children with cystinuria treated at our clinic using a gradual dose escalation of penicillamine. "
12/01/2008 - "We evaluated the effects of penicillamine in preventing stone formation and with respect to toxicity in our cystinuria cohort at a pediatric biochemical genetics clinic. "
03/01/1978 - "On the basis or a study of 50 cases of rheumatoid polyarthritis treated with D penicillamine comments are made on the failure of this form of treatment by comparison of the apparent and real efficacy. "
12/01/1977 - "[Study of optimal posology of penicillamine in the treatment of common rheumatoid polyarthritis (apropos of a personal series of 200 cases)]."
10/01/1972 - "[Study of various parameters of cellular and humoral immunity during the treatment of rheumatoid polyarthritis with D-penicillamine]."
02/01/1970 - "[Penicillamine and rheumatoid polyarthritis (study of 9 cases)]."
05/01/1991 - "D-penicillamine, on the other hand, showed no beneficial effects on arthritis except for inhibiting new bone formation. "
|5.||Systemic Scleroderma (Systemic Sclerosis)
08/01/1985 - "These data suggest that D-penicillamine may be useful in the treatment of systemic sclerosis that involves the lung; however, further studies are needed."
06/01/2013 - "From a dermatologic standpoint, penicillamine was found to be useful in the treatment of systemic sclerosis. "
12/01/1999 - "[D-penicillamine: an outdated cure for systemic scleroderma?]."
06/01/2001 - "To compare the systemic sclerosis (SSc) patients entered into the d-penicillamine trial with SSc patients entered into previous controlled SSc trials. "
03/01/2001 - "The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial."
|1.||Chelation Therapy (Therapy, Chelation)
|2.||Drug Therapy (Chemotherapy)